CSIMarket
 
Danaher Corporation  (NYSE: DHR)
    Sector  Technology    Industry IT Infrastructure
   Industry IT Infrastructure
   Sector  Technology
 
Price: $202.3300 $-2.90 -1.413%
Day's High: $205.99000549316406 Week Perf: -3.61 %
Day's Low: $ 201.95 30 Day Perf: -3.36 %
Volume (M): 347,447 52 Wk High: $ 242.80
Volume (M$): $ 0 52 Wk Avg: $203.51
Open: $206.00 52 Wk Low: $160.93



 Market Capitalization (Millions $) 143,169
 Shares Outstanding (Millions) 708
 Employees 60,000
 Revenues (TTM) (Millions $) 25,107
 Net Income (TTM) (Millions $) 4,004
 Cash Flow (TTM) (Millions $) 2,744
 Capital Exp. (TTM) (Millions $) 1,169

Business Description


Danaher Corporation derives its sales from the design, manufacture and marketing of industrial and consumer products, which are typically characterized by strong brand names, proprietary technology and major market positions, in three business segments: Professional Instrumentation, Industrial Technologies, and Tools & Components.

The Company strives to create shareholder value through:

delivering sales growth, excluding the impact of acquired businesses, in excess of the overall market growth for its products and services;

upper quartile financial performance when compared against peer companies; and

upper quartile cash flow generation from operations when compared against peer companies.

To accomplish these goals, the Company uses a set of tools and processes, known as the DANAHER BUSINESS SYSTEM ('DBS'), which are designed to continuously improve business performance in critical areas of quality, delivery, cost and innovation. The Company also acquires businesses that it believes can help it achieve the objectives described above. The Company will acquire businesses when they strategically fit with existing operations or when they are of such a nature and size as to establish a new strategic line of business.

The Company's manufacturing operations employ a wide variety of raw materials.' While certain raw materials such as steel and certain electrical components are subject to supply constraints, Danaher believes that it will generally be able to obtain adequate supplies of major raw material requirements or reasonable substitutes at reasonable costs.

Competition

Our served markets are generally highly competitive and global in nature.'Because of the diversity of products the Company manufactures and the variety of markets it serves, the Company encounters a wide variety of competitors. The Company faces numerous regional or specialized competitors, many of which are well-established in their markets.'In addition, some of the Company's competitors are larger companies or divisions of larger companies that have greater sales, marketing, research, and financial resources than the Company. Key competitive factors typically include price, quality, delivery speed, service and support, innovation, product features and performance, and brand name.



   Company Address: 2200 Pennsylvania Avenue, N.W., Suite 800W Washington, 20037 DC
   Company Phone Number: 828-0850   Stock Exchange / Ticker: NYSE DHR


Customers Net Income grew by DHR's Customers Net Profit Margin fell to

9.62 %

9.78 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CETX   -1.38%    
ITRI        0.3% 
ROP   -6.33%    
VPG        6.27% 
BRKA        1.5% 
HON   -1.69%    
• View Complete Report
   



Announcement

Investor Scrutiny on Danaher Corporation Analyzing Potential Fiduciary Breaches Amid Lagging Revenue Performance

Published Wed, Sep 24 2025 12:57 AM UTC

NEW YORK, Sept. 23, 2025 The Rosen Law Firm, a premier global investor rights legal team, has initiated an investigation into the fiduciary duties of the directors and officers of Danaher Corporation (NYSE: DHR). This comes in light of disturbing financial trends that not only put Danaher’s market standing at risk but call into question the stewardship of its leadership.In...

Personnel Announcements

Molecular Devices Elects Mary Duseau as President, Spearheading a New Era of Innovation and Growth

Published Wed, Mar 13 2024 12:05 PM UTC

Molecular Devices Appoints Mary Duseau as President, Bringing 25 Years of Experience in Life Sciences
Molecular Devices, a prominent provider of high-performance life science solutions and an operating company within the life sciences segment of Danaher Corporation, has made a significant leadership change. Today, the company announced the appointment of Mary Duseau as...

Business Update

Danaher Secures High Court Approval for Abcam Acquisition, Paving the Way for Advancements in Life Science Research

Published Mon, Dec 4 2023 9:01 PM UTC


In a significant development for the global life science research tools industry, Abcam plc (Nasdaq: ABCM), a renowned leader in the field, has received approval from the High Court of Justice of England and Wales for its proposed acquisition by Danaher Corporation (NYSE: DHR). The deal, valued at $24.00 per share in cash, signifies a strategic move by Danaher to expand...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 36.00
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 5.70
Price to Sales (Expected) -
Price to Book 2.72
PEG (TTM) 1.79

Financial Strength Current
Quick Ratio -
Working Capital Ratio 1.65
Leverage Ratio (MRQ) 0.76
Total Debt to Equity 0.53
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.35

Per Share Current
Earnings (TTM) 5.62 $
Revenues (TTM) 35.48 $
Cash Flow (TTM) 3.88 $
Cash -
Book Value 74.32 $
Dividend (TTM) 1.27 $

Efficiency Current
Revenue per Employee (TTM) 418,450
Net Income per Employee (TTM) 66,733
Receivable Turnover Ratio (TTM) 6.5
Inventory Turnover Ratio (TTM) 3.78
Asset Turnover Ratio (TTM) 0.3

Profitability Ratios Current
Gross Margin (MRQ) 57.64 %
Operating Margin (MRQ) 17.99 %
Net Margin (MRQ) 13.89 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) 16.21 %

Management Effectiveness Current
Return On Assets (TTM) 4.72 %
Return On Investment (TTM) 5.44 %
Return On Equity (TTM) 7.66 %
Dividend Yield 0.47 %
Pay out Ratio (TTM) 22.6 %



Danaher's Segments
Recurring revenue    84.54 % of total Revenue
Nonrecurring revenue    15.46 % of total Revenue
North America    41.64 % of total Revenue
Western Europe    26.3 % of total Revenue
Other developed markets    4.77 % of total Revenue
High-growth markets    27.29 % of total Revenue
segments    100 % of total Revenue
Biotechnology    30.2 % of total Revenue
Biotechnology Recurring revenue    27.59 % of total Revenue
Biotechnology Nonrecurring revenue    2.6 % of total Revenue
Biotechnology North America    8.81 % of total Revenue
Biotechnology Western Europe    12.2 % of total Revenue
Biotechnology Other developed markets    0.96 % of total Revenue
Biotechnology High-growth markets    8.23 % of total Revenue
Life Sciences    29.19 % of total Revenue
Life Sciences Recurring revenue    20.22 % of total Revenue
Life Sciences Nonrecurring revenue    8.97 % of total Revenue
Life Sciences North America    11.58 % of total Revenue
Life Sciences Western Europe    6.86 % of total Revenue
Life Sciences Other developed markets    2.37 % of total Revenue
Life Sciences High-growth markets    8.39 % of total Revenue
Diagnostics    40.62 % of total Revenue
Diagnostics Recurring revenue    36.73 % of total Revenue
Diagnostics Nonrecurring revenue    3.88 % of total Revenue
Diagnostics North America    21.26 % of total Revenue
Diagnostics Western Europe    7.24 % of total Revenue
Diagnostics Other developed markets    1.45 % of total Revenue
Diagnostics High-growth markets    10.67 % of total Revenue
Biotechnology segments    30.2 % of total Revenue
Life Sciences segments    29.19 % of total Revenue
Diagnostics segments    40.62 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.